EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Ltd.

CAPLIPOINT

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

NSE: CAPLIPOINTOfficial website ↗

Key metrics

Market Cap

₹13,008 cr

P/E Ratio

21.23x

P/B Ratio

4.56x

ROE

18.81%

ROCE

23.72%

Debt / Equity

0x

Net Margin

27.68%

Dividend Yield

35%

EPS

₹70.25

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 73.68%FII: 5.36%Public: 20.96%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Caplin Point Laboratories Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.